Vascular Graft Market by Product (Hemodialysis Access Graft, Endovascular Aneurysm Repair Stent Graft, and Peripheral Vascular Graft), by Raw Material (Polyester, Polytetrafluoroethylene (PTFE), Polyurethane, and Biosynthetic), and by End-User (Hospitals and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2017-2023
A vascular graft is a medical device that acts as an artificial blood vessel. It is implanted in patients with blocked blood vessels to redirect the flow of blood from one organ to the other to restore the normal flow of blood within the body.
The global vascular graft market is driven by increase in the incidence of vascular disorders, high blood glucose level, hypertension, and other risk factors that cause blockage of blood vessels. The global vascular grafts market was valued at $4,192 million in 2016, and is expected to reach at $6,218 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. In addition, sedentary lifestyle, rise in geriatric population, and technological advancements supplement the market growth. However, high cost of treatment and increase in complications associated with prosthetic grafts restrain the market growth. Conversely, rise in awareness for vascular grafts and huge market opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities to the market players in the near future.
The global vascular graft market is segmented on the basis of product, raw material, end user, and region. On the basis of product, it is classified into endovascular stent graft, peripheral vascular graft, and hemodialysis access graft. The endovascular stent graft segment is bifurcated into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). On the basis of raw material, it is categorized into polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. Based on end user, it is divided into hospitals & ambulatory surgical centers. The market is analyzed based on region into North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
By Product
The global vascular graft market is driven by increase in the incidence of vascular disorders, high blood glucose level, hypertension, and other risk factors that cause blockage of blood vessels. The global vascular grafts market was valued at $4,192 million in 2016, and is expected to reach at $6,218 million by 2023, growing at a CAGR of 5.7% from 2017 to 2023. In addition, sedentary lifestyle, rise in geriatric population, and technological advancements supplement the market growth. However, high cost of treatment and increase in complications associated with prosthetic grafts restrain the market growth. Conversely, rise in awareness for vascular grafts and huge market opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide numerous opportunities to the market players in the near future.
The global vascular graft market is segmented on the basis of product, raw material, end user, and region. On the basis of product, it is classified into endovascular stent graft, peripheral vascular graft, and hemodialysis access graft. The endovascular stent graft segment is bifurcated into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). On the basis of raw material, it is categorized into polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. Based on end user, it is divided into hospitals & ambulatory surgical centers. The market is analyzed based on region into North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
- Comprehensive analyses of the product type and raw materials help in understanding the regional trends and potential investment areas.
- Key market players and their strategies have been thoroughly analyzed to understand the competitive outlook of the industry.
By Product
- Hemodialysis Access Graft
- Endovascular Aneurysm Repair Stent Grafts
- Abdominal Aortic Aneurysm (AAA)
- Thoracic Aortic Aneurysm (TAA)
- Peripheral Vascular Graft
- Polytetrafluoroethylene (PTFE)
- Polyurethane (PU)
- Polyester
- Biosynthetic
- Hospitals
- Ambulatory Surgical Centers
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- B. Braun Melsungen AG
- C. R. Bard Inc.
- Cardinal Health Inc.
- Cook Medical Inc.
- Endologix Inc.
- LeMaitre Vascular Inc.
- MAQUET Holding B.V. & Co. KG (a Getinge Group Company)
- Medtronic plc.
- Terumo Corporation
- W. L. Gore & Associates Inc.
- Cardiatis SA
- JOTEC GmbH
- Lombard Medical Inc.
- Japan Lifeline Co. Ltd.
- Nano Endoluminal
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. TOP PLAYER POSITIONING, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Rise in incidence of risk factors that lead to blockage of blood vessels
3.4.1.2. Increase in geriatric population
3.4.1.3. Technological advancements
3.4.1.4. Lifestyle changes leading to blockage of blood vessels
3.4.2. Restraints
3.4.2.1. High cost of treatment
3.4.2.2. Complications associated with prosthetic grafts
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Increase in awareness for vascular grafts
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 GLOBAL VASCULAR GRAFT MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HEMODIALYSIS ACCESS GRAFT
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
4.3.1. Abdominal Aortic Aneurysm (AAA)
4.3.2. Thoracic Aortic Aneurysm (TAA)
4.3.3. Key market trends
4.3.4. Key growth factors and opportunities
4.3.5. Market size and forecast
4.4. PERIPHERAL VASCULAR GRAFT
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 VASCULAR GRAFT MARKET, BY RAW MATERIAL
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. POLYESTER
5.2.1. Market size and forecast
5.3. POLYTETRAFLUOROETHYLENE (PTFE)
5.3.1. Market size and forecast
5.4. POLYURETHANE
5.4.1. Market size and forecast
5.5. BIOSYNTHETIC
5.5.1. Market size and forecast
CHAPTER 6 VASCULAR GRAFT MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. AMBULATORY SURGICAL CENTERS (ASCS)
6.3.1. Market size and forecast
CHAPTER 7 VASCULAR GRAFT MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Italy
7.3.8. Spain
7.3.9. Rest of Europe
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan
7.4.5. China
7.4.6. India
7.4.7. South Korea
7.4.8. Australia
7.4.9. Rest of Asia-Pacific
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. South Africa
7.5.6. Saudi Arabia
7.5.7. Rest of LAMEA
CHAPTER 8 COMPANY PROFILES
8.1. B. BRAUN MELSUNGEN AG
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.8. Key strategic moves and developments
8.2. C. R. BARD, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. CARDINAL HEALTH INC.
8.3.1. Company overview
8.3.2. Company Snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.8. Key strategic moves and developments
8.4. COOK MEDICAL INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Key strategic moves and developments
8.5. ENDOLOGIX INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.8. Key strategic moves and developments
8.6. LEMAITRE VASCULAR, INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.8. Key strategic moves and developments
8.7. MAQUET HOLDING B.V. & CO. KG
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. MEDTRONIC PLC
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. TERUMO CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating product categories
8.9.4. Product portfolio
8.9.5. Business performance
8.9.8. Key strategic moves and developments
8.10. W. L. GORE & ASSOCIATES, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. TOP PLAYER POSITIONING, 2016
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Rise in incidence of risk factors that lead to blockage of blood vessels
3.4.1.2. Increase in geriatric population
3.4.1.3. Technological advancements
3.4.1.4. Lifestyle changes leading to blockage of blood vessels
3.4.2. Restraints
3.4.2.1. High cost of treatment
3.4.2.2. Complications associated with prosthetic grafts
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Increase in awareness for vascular grafts
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
CHAPTER 4 GLOBAL VASCULAR GRAFT MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. HEMODIALYSIS ACCESS GRAFT
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.3. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
4.3.1. Abdominal Aortic Aneurysm (AAA)
4.3.2. Thoracic Aortic Aneurysm (TAA)
4.3.3. Key market trends
4.3.4. Key growth factors and opportunities
4.3.5. Market size and forecast
4.4. PERIPHERAL VASCULAR GRAFT
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 VASCULAR GRAFT MARKET, BY RAW MATERIAL
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. POLYESTER
5.2.1. Market size and forecast
5.3. POLYTETRAFLUOROETHYLENE (PTFE)
5.3.1. Market size and forecast
5.4. POLYURETHANE
5.4.1. Market size and forecast
5.5. BIOSYNTHETIC
5.5.1. Market size and forecast
CHAPTER 6 VASCULAR GRAFT MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. HOSPITALS
6.2.1. Market size and forecast
6.3. AMBULATORY SURGICAL CENTERS (ASCS)
6.3.1. Market size and forecast
CHAPTER 7 VASCULAR GRAFT MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Italy
7.3.8. Spain
7.3.9. Rest of Europe
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan
7.4.5. China
7.4.6. India
7.4.7. South Korea
7.4.8. Australia
7.4.9. Rest of Asia-Pacific
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. South Africa
7.5.6. Saudi Arabia
7.5.7. Rest of LAMEA
CHAPTER 8 COMPANY PROFILES
8.1. B. BRAUN MELSUNGEN AG
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.8. Key strategic moves and developments
8.2. C. R. BARD, INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments
8.3. CARDINAL HEALTH INC.
8.3.1. Company overview
8.3.2. Company Snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.8. Key strategic moves and developments
8.4. COOK MEDICAL INC.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Key strategic moves and developments
8.5. ENDOLOGIX INC.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.8. Key strategic moves and developments
8.6. LEMAITRE VASCULAR, INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.8. Key strategic moves and developments
8.7. MAQUET HOLDING B.V. & CO. KG
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Key strategic moves and developments
8.8. MEDTRONIC PLC
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Key strategic moves and developments
8.9. TERUMO CORPORATION
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating product categories
8.9.4. Product portfolio
8.9.5. Business performance
8.9.8. Key strategic moves and developments
8.10. W. L. GORE & ASSOCIATES, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
LIST OF TABLES
TABLE 1. GLOBAL VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. HEMODIALYSIS ACCESS GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. PERIPHERAL VASCULAR GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 7. VASCULAR GRAFTS MARKET FOR POLYESTER, BY REGION, 2016-2023 ($MILLION)
TABLE 8. VASCULAR GRAFTS MARKET FOR PTFE, BY REGION, 2016-2023 ($MILLION)
TABLE 9. VASCULAR GRAFTS MARKET FOR POLYURETHANE, BY REGION, 2016-2023 ($MILLION)
TABLE 10. VASCULAR GRAFTS MARKET FOR BIOSYNTHETIC, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 12. VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. VASCULAR GRAFTS MARKET FOR ASCS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. VASCULAR GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. EUROPE VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 21. EUROPE VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 22. EUROPE VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. LAMEA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. LAMEA VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. LAMEA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 30. LAMEA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 32. B. BRAUN MELSUNGEN AG: OPERATING BUSINESS SEGMENTS
TABLE 33. C. R. BARD, INC.: COMPANY SNAPSHOT
TABLE 34. C. R. BARD, INC.: OPERATING BUSINESS SEGMENTS
TABLE 35. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
TABLE 36. CARDINAL HEALTH INC.: OPERATING BUSINESS SEGMENTS
TABLE 37. COOK MEDICAL INC.: COMPANY SNAPSHOT
TABLE 38. COOK MEDICAL INC.: PRODUCT CATEGORIES
TABLE 39. ENDOLOGIX INC.: COMPANY SNAPSHOT
TABLE 40. ENDOLOGIX INC.: OPERATING BUSINESS SEGMENTS
TABLE 41. LEMAITRE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 42. LEMAITRE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 43. MAQUET HOLDING B.V. & CO. KG: COMPANY SNAPSHOT
TABLE 44. MAQUET HOLDING B.V. & CO. KG: OPERATING BUSINESS SEGMENTS
TABLE 45. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 46. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS
TABLE 47. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 48. TERUMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 49. W. L. GORE & ASSOCIATES, INC.: COMPANY SNAPSHOT
TABLE 50. W. L. GORE & ASSOCIATES, INC.: OPERATING BUSINESS SEGMENTS
TABLE 1. GLOBAL VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. HEMODIALYSIS ACCESS GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 4. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. PERIPHERAL VASCULAR GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 7. VASCULAR GRAFTS MARKET FOR POLYESTER, BY REGION, 2016-2023 ($MILLION)
TABLE 8. VASCULAR GRAFTS MARKET FOR PTFE, BY REGION, 2016-2023 ($MILLION)
TABLE 9. VASCULAR GRAFTS MARKET FOR POLYURETHANE, BY REGION, 2016-2023 ($MILLION)
TABLE 10. VASCULAR GRAFTS MARKET FOR BIOSYNTHETIC, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 12. VASCULAR GRAFTS MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. VASCULAR GRAFTS MARKET FOR ASCS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. VASCULAR GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. NORTH AMERICA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 19. EUROPE VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 21. EUROPE VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 22. EUROPE VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 27. LAMEA VASCULAR GRAFTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. LAMEA VASCULAR GRAFTS MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. LAMEA VASCULAR GRAFTS MARKET, BY RAW MATERIAL, 2016-2023 ($MILLION)
TABLE 30. LAMEA VASCULAR GRAFTS MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 31. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 32. B. BRAUN MELSUNGEN AG: OPERATING BUSINESS SEGMENTS
TABLE 33. C. R. BARD, INC.: COMPANY SNAPSHOT
TABLE 34. C. R. BARD, INC.: OPERATING BUSINESS SEGMENTS
TABLE 35. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
TABLE 36. CARDINAL HEALTH INC.: OPERATING BUSINESS SEGMENTS
TABLE 37. COOK MEDICAL INC.: COMPANY SNAPSHOT
TABLE 38. COOK MEDICAL INC.: PRODUCT CATEGORIES
TABLE 39. ENDOLOGIX INC.: COMPANY SNAPSHOT
TABLE 40. ENDOLOGIX INC.: OPERATING BUSINESS SEGMENTS
TABLE 41. LEMAITRE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 42. LEMAITRE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 43. MAQUET HOLDING B.V. & CO. KG: COMPANY SNAPSHOT
TABLE 44. MAQUET HOLDING B.V. & CO. KG: OPERATING BUSINESS SEGMENTS
TABLE 45. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 46. MEDTRONIC PLC: OPERATING BUSINESS SEGMENTS
TABLE 47. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 48. TERUMO CORPORATION: OPERATING BUSINESS SEGMENTS
TABLE 49. W. L. GORE & ASSOCIATES, INC.: COMPANY SNAPSHOT
TABLE 50. W. L. GORE & ASSOCIATES, INC.: OPERATING BUSINESS SEGMENTS
LIST OF FIGURES
FIGURE 1. VASCULAR GRAFT MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, VASCULAR GRAFT MARKET, 2016
FIGURE 9. IMPACT ANALYSIS: VASCULAR GRAFT MARKET
FIGURE 10. GEOGRAPHICAL DISTRIBUTION OF COMPLETED CLINICAL TRIALS IN VASCULAR GRAFT MARKET (%)
FIGURE 11. U.S. VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 12. CANADA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 13. MEXICO VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 14. GERMANY VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 15. FRANCE VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 16. UK VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 17. ITALY VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 18. SPAIN VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 19. REST OF EUROPE VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 20. JAPAN VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 21. CHINA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 22. INDIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 23. SOUTH KOREA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 24. AUSTRALIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 25. REST OF ASIA-PACIFIC VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 26. BRAZIL VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 27. SOUTH AFRICA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 28. SAUDI ARABIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 29. REST OF LAMEA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 30. B. BRAUN MELSUNGEN AG: FINANCIALS, 2014-2016 ($MILLION)
FIGURE 1. VASCULAR GRAFT MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, VASCULAR GRAFT MARKET, 2016
FIGURE 9. IMPACT ANALYSIS: VASCULAR GRAFT MARKET
FIGURE 10. GEOGRAPHICAL DISTRIBUTION OF COMPLETED CLINICAL TRIALS IN VASCULAR GRAFT MARKET (%)
FIGURE 11. U.S. VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 12. CANADA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 13. MEXICO VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 14. GERMANY VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 15. FRANCE VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 16. UK VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 17. ITALY VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 18. SPAIN VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 19. REST OF EUROPE VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 20. JAPAN VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 21. CHINA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 22. INDIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 23. SOUTH KOREA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 24. AUSTRALIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 25. REST OF ASIA-PACIFIC VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 26. BRAZIL VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 27. SOUTH AFRICA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 28. SAUDI ARABIA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 29. REST OF LAMEA VASCULAR GRAFT MARKET ($MILLION), 2016-2023
FIGURE 30. B. BRAUN MELSUNGEN AG: FINANCIALS, 2014-2016 ($MILLION)
